Geoffrey M.
Drake

Represented Merck in multidistrict litigation (MDL) involving allegations of injuries from use of the company’s osteoporosis medication, including in three bellwether trials in two different MDLs. In Glynn v. Merck, the jury returned a complete defense verdict, after which the court granted judgment based on federal preemption.

Serving as one of a core group of partners leading the national coordinating and trial counsel team representing GlaxoSmithKline in nationwide litigation concerning allegations of suicidality and birth defects from use of the company’s antidepressant.

Representing Renco Group and Doe Run Resources in mass tort litigation in federal court in St. Louis concerning personal-injury allegations by several thousand Peruvian children allegedly exposed to contaminants from a smelter in the Andean Highlands.

Representing healthcare companies and employers in multiple COVID-19-related wrongful death lawsuits.

Representing Coloplast as part of the team serving as National Coordinating and Trial Counsel in nationwide product liability litigation relating to injuries allegedly caused by the company’s female pelvic mesh devices.

Serving as National Counsel for Viking Group, Inc. with respect to claims and lawsuits relating to property damage arising from alleged manufacturing or design defects in fire suppression equipment.

Serving as Co-Coordinating and Strategic Counsel to a U.S. automobile manufacturer in connection with over 1500 breach of warranty and consumer fraud lawsuits pending in California state and federal courts; previously co-led team representing another U.S. automobile manufacturer in hundreds of breach of warranty and consumer-fraud lawsuits in California.

Representing the manufacturer of FDA-cleared surgical gowns in nationwide litigation concerning the design, labeling, advertising and manufacture of the devices, including: a federal class action trial; a qui tam suit brought under the Federal False Claims Act in which the court granted defendants' motion to dismiss; and a federal Lanham Act lawsuit concerning allegations of false marketing.

Represented Purdue Pharma in an action filed by the Kentucky Attorney General seeking Medicaid-related costs and other damages allegedly caused by the company’s marketing and promotion of its prescription pain medication.

Represented DaVita Healthcare Partners in a qui tam case brought under the federal False Claims Act claiming improper billing of Medicare for unnecessary wastage of two medications used to treat dialysis patients.

Represented a leading automobile manufacturer in connection with government investigations and multi-jurisdictional civil litigation relating to a series of high-profile vehicle recalls.

Represented the owner of petroleum pipeline terminals in federal MDL proceedings in an action filed by the Pennsylvania Attorney General involving claims of groundwater contamination from MTBE-containing gasoline.

Represented Lincoln Electric Company and other manufacturers in cases involving claims from exposure to manganese fumes from welding rods, and serving as national discovery counsel in the litigation for Eutectic Corporation.

Represented Cooper Industries, the successor of a former operator of a Superfund site, in litigation involving allegations of a variety of personal injuries from PCB exposure.

Represented Phillips Services Corp. in a class action lawsuit involving nuisance allegations arising from the release of odors from a wastewater treatment facility.